Furthermore, a study by Vandikas et al. on patients with psoriasis treated with etanercept found that those with sufficient levels of serum 25(OH)D at the start of TNF-α inhibitor therapy improved more rapidly on the Visual Analogue Scale (VAS) than those with insufficient levels [22]. The gene discussed is TNF; the disease is psoriasis.